Golden
Exopharm

Exopharm

Exopharm is a regenerative medicine biopharmaceutical company spun out of Altnia Group. Founded in 2003 and based in Melbourne, Australia, the company aims to develop and commercialize exosomes as therapeutic agents.

Exopharm's products include Plexaris, exosomes derived from human platelets, and Exomeres, exosomes from stem cells.Exosomes are extracellular vesicles involved in cell-cell communication and transmission of disease states through transfer of protein, RNA, lipids and microRNA. Exosomes are thought to mediate some of the regenerative effects of stem cells and provide a cell-free therapeutic agent with therapeutic benefits.The company aims to treat diseases such as dry Age Related Macular Degeneration (AMD), tendinopathy, arthritis, cardiac repair, neurodegeneration and aging.





Exopharm's proprietary LEAP Technology provides a key step in the downstream manufacturing process to isolate and purify exosomes from adult stem cells and other sources which claims to address existing limitations in exosome purification processes. Exopharm's technology is designed for the manufacture of a proprietary exosome product at clinical and then pharmaceutical grade and scale.



The Stem Cell Exomere Program is a partnership between RoosterBio and Exopharm to develop and implement a standardized, scalable, commercially-viable biomanufacturing process and a cGMP-compliant Exomere product (exosomes) for regenerative medicine applications.













Timeline

People

Name
Role
LinkedIn

David Parker

Non-Executive Director



Gregor Lichtfuss, MSc, DTMPH

Technology Co-Founder and Chief Operating Officer



Ian Dixon, PhD, MBA, MAICD

Company Founder, Technology Co-Founder and Managing Director



Jason Watson

Non-Executive Chairman



Further reading

Title
Author
Link
Type
Date

Exopharm company spun out to commercialise a completely new type of nano-drug for regenerative medicine

Medianet

Web



Stem Cell Exomere Program announced by RoosterBio and Exopharm

Prweb

Web



Documentaries, videos and podcasts

Title
Date
Link

Exopharm CA MIX2 20181019

December 27, 2018

Companies

Company
CEO
Location
Products/Services









References